4//SEC Filing
Ho William Tai-Wei 4
Accession 0001415889-25-012290
CIK 0001740279other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 8:45 PM ET
Size
13.7 KB
Accession
0001415889-25-012290
Insider Transaction Report
Form 4
IN8BIO, INC.INAB
Ho William Tai-Wei
DirectorPRESIDENT AND CEO10% Owner
Transactions
- Disposition to Issuer
Series B Warrants (right to buy)
2025-04-27−81,967→ 0 totalExercise: $1.50Exp: 2028-12-13→ Common Stock (81,967 underlying) - Award
Pre-Funded Warrant (right to buy)
2025-05-01$0.18/sh+81,967$15,107→ 81,967 totalExercise: $0.00→ Common Stock (81,967 underlying) - Award
Series B Warrants (right to buy)
2025-04-27+81,967→ 81,967 totalExercise: $0.45Exp: 2028-12-13→ Common Stock (81,967 underlying) - Disposition to Issuer
Series A Warrants (right to buy)
2025-05-01−81,967→ 0 totalExercise: $0.45Exp: 2025-10-04→ Common Stock (81,967 underlying)
Footnotes (6)
- [F1]The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.
- [F2]Fully vested and exercisable.
- [F3]The reported securities are included within 81,967 units purchased by the Reporting Person on December 13, 2023 for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock.
- [F4]Pursuant to an Exchange Letter Agreement, dated April 26, 2025 (the "Exchange Agreement"), by and between the Company and the Reporting Person, the Reporting Person surrendered to the Company for cancellation the Series A Warrants for a like number of Pre-Funded Warrants to purchase common stock, with a per share exercise price of $0.0001 per share.
- [F5]The reported securities are included within 81,967 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock.
- [F6]The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. The Pre-Funded Warrants are subject to certain exercise limitations.
Documents
Issuer
IN8BIO, INC.
CIK 0001740279
Entity typeother
Related Parties
1- filerCIK 0001830914
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 8:45 PM ET
- Size
- 13.7 KB